The Wisconsin Society of Addiction Medicine hosted the Buprenorphine from the Emergency Department: Basics and Beyond webinar on Wednesday, March 27 from 12:00 - 2:30 p.m.
Training was coordinated by Wisconsin Society of Addiction Medicine as part of the ORP
Speakers:
Learning Objectives:
WISAM is offering Enduring CME for this training until March 27, 2025. Register and you will receive a link to the webinar recording and CME instructions.
____________________________________________________________________________
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and WISAM. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity / enduring materials for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Wisconsin Society of Addiction Medicine hosted the Quick Start to Treatment of Opioid Use Disorders: Buprenorphine Focus Course webinar on Thursday, August 15 from 12:30-2:30 p.m.
This course was created by WISAM, in order to provide Primary Care Providers who are interested in treating opioid use disorders the opportunity to learn more and ask questions.
Learning Objectives:At the end of the course, the participant will be able to:
WISAM is offering Enduring CME for this training until August 15, 2025. Register and you will receive a link to the webinar recording and CME instructions.
Joint Accreditation StatementIn support of improving patient care, this activity has been planned and implemented by Amedco LLC and WISAM. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Physicians (ACCME) Credit DesignationAmedco LLC designates this live activity / enduring materials for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
US overdose deaths associated with stimulants (cocaine and methamphetamine) are now only exceeded by deaths associated with fentanyl. Because most cocaine and methamphetamine now being used in the US now contains fentanyl and because the methamphetamine currently being produced is more lethal than in past years, these drugs are extremely dangerous and damaging to the body and brain. Individuals who use stimulants are challenging to engage and retain in treatment and they present unique clinical issues in treatment. There are no FDA-approved medications for treatment of stimulant use disorder, although several are promising. Behavioral treatment, especially the use of contingency management (and other approaches with supportive evidence), has by far the best evidence of effectiveness. The presentation will review these topic areas of importance to clinicians treating individuals with stimulant use disorder.
Speaker: Richard Rawson, PhD
Learning Objectives include:
WISAM is offering Enduring CME for this training until September 26, 2027. Register here and you will receive a link to the webinar recording and CME instructions. This online learning session and CME credit is coordinated by WISAM as part of the ORP.
Accreditation & Credit Designation Statements In support of improving patient care, this activity has been planned and implemented by Wisconsin Society of Addiction Medicine and American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians The American Society of Addiction Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
View Full Learner Statement Here
This presentation will focus on stimulant use in a broad sense. We will discuss the neurobiological effects of specific stimulant groups as well as specific symptoms of intoxication and washout. We will also discuss data for stimulant use disorder/washout management based on ASAM guidelines. Management strategies will include both non-pharmacological interventions and potential pharmacological options aimed at treating washout/intoxication as well as stimulant use disorder.
Speaker: Jeremiah Fairbanks, MD
The purpose of this workshop is to describe efforts by addiction specialists to bridge some of these identified gaps by collaborating with providers in different parts of the healthcare system. It will include opportunities for the attendees to consider what needs exist in their systems and communities, as well as how to identify and connect with community stakeholders and partners who are important to the continuum of care needed for the treatment of SUD.
Speakers: Ritu Bhatnagar, MD, MPH, Virginia Medinilla, MD, PhD, and Ezra Lyon, MD
Physicians The American Society of Addiction Medicine designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Wisconsin is due to receive more than $750 million in opioid settlement funds through 2038. This is a historic opportunity to invest, expand, and strengthen prevention, harm reduction, treatment, and recovery services across the state. This session will provide details on how these dollars are split between the state and local governments that participated in this litigation, how the Wisconsin Department of Health Services develops their annual spending plan for the state’s portion of funds, and the impact of these funds over the last few years.
Speaker: Michelle Haese, CAPSW, CSAC
Good Samaritan Legislation (GSL) can offer legal protections for people who call 911 in the event of an overdose and can offer protections for the overdose survivor. However, GSL looks different in different states, with some laws offering stronger protections than others. The Wisconsin GSL is particularly weak, which leads to many individuals who call for help and who survive overdose ending up with legal charges and periods of incarceration. During this session, the speakers will describe the legislative process in Wisconsin (Mark Grapentine), the evidence behind GSL (Elizabeth Salisbury-Afshar), the WI GSL in current state and how we are hoping it can improve in the future (Elizabeth Salisbury-Afshar), and describe the Wisconsin Good Samaritan Coalition’s efforts and ways to get involved moving forward (Annette Czarnecki).
Speakers: Elizabeth Salisbury-Afshar, MD, MPH, Mark Grapentine, JD, and Annette Czarnecki
The opioid overdose crisis poses a significant public health challenge, necessitating innovative approaches to broaden access to evidence-based treatments for opioid use disorder (OUD). Feedback from various community providers in the Dane County area, including the emergency department, EMS, inpatient addiction consult service, and the criminal-legal system, has highlighted challenges in referring individuals for immediate access to medications for opioid use disorder treatment (MOUD) due to insurance limitations, network constraints, and long waitlists. In response, we prioritized establishing a clinic offering open access to care for anyone seeking help, irrespective of payer. This clinic model aims to mitigate these barriers by providing same-day access to medications for opioid use disorder (MOUD), facilitated by a grant from the Department of Human Services (DHS), covering medical visits, labs, and MOUD. Through our presentation, we will provide insights into the clinic's goals, objectives, alignment with SAMHSA low barrier treatment guidelines, and the collaborative approach.
Through our presentation, we aim to provide insights into the clinic's goals, objectives, alignment with SAMHSA low barrier treatment guidelines, and the collaborative approach involving an interdisciplinary team comprising of a prescriber, registered nurse care coordinator, medical assistant, and peer support specialist. Additionally, we will address the challenges encountered during the operational phase, lessons learned, and strategies for ongoing improvement.
Speakers: Maggie Williams, MPAS, PA-C, CPAAPA, Madison Simpson, RN, BSN, and Wesley Arnett
This talk is intended for addiction medicine providers who are not psychiatrists and will provide an overview of common co-occurring disorders and practical strategies for evaluating and managing those conditions. This presentation will review common diagnoses and treatments through the lens of psychiatrists but will also distill actionable guidance, effective treatment strategies and pragmatic tips for non-psychiatrists including tenets of harm reduction psychotherapies. We will provide effective interviewing techniques and evidence-based treatment strategies that a non-psychiatrist can utilize for commonly occurring psychiatric conditions (including anxiety disorders, borderline personality disorder, treatment resistant depression, post-traumatic stress disorder and psychotic conditions) and common scenarios in COD treatment. We will pay particular attention to the complicated relationship between methamphetamine use disorder and commonly co-occurring disorders, which can complicate treatment such as psychosis and attention-deficit hyperactivity disorder. Participants will leave the session with more confidence in practicing the basics of co-occurring psychiatric management for their patients with SUDs.
Speakers: Brent Schnipke, MD, Gayane Archer, MD, and Daniel Fisher, MD
By the end of the workshop, participants will have a deeper understanding of stigma and bias within healthcare settings, feel empowered to challenge and address these issues, and have developed a plan for promoting equity and inclusivity as they work alongside people with lived experience. This workshop aims to create a community of support and empowerment among Peer Providers in their mission to break barriers and create a more inclusive healthcare environment.
Speaker: Tanya Kraege, MSW, LCSW, CSAC
People who identify as Black, Indigenous, and People of Color (BIPOC), sexual and gender minorities, and people with disabilities experience disproportionately high rates of physical and psychosocial consequences of substance use and addiction and lower access to evidence-based treatments. This presentation will give learners an overview of the relationship between racism, discrimination and inequities in substance use-related consequences and treatment access; organizational assessment of diversity, equity, inclusion, and belonging (DEIB) climates; and best practices for implementing policies and practices that integrate cultural humility and an equity-focused lens into addiction treatment and recovery services.
Speaker: Anika Alvanzo, MD, MS, FACP, DFASAM
Wisconsin Society of Addiction Medicine563 Carter Court, Suite B,Kimberly, WI 54136
